Drug intelligence / Profile preview

Antisettico Astringente Sedativo

Development stage
Unknown
Lead developer
Bruschettini
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

**Antisettico Astringente Sedativo** is a fixed-dose combination ophthalmic solution developed and marketed by Bruschettini for the treatment of simple conjunctivitis and other minor ocular inflammations and infections. The formulation combines four active ingredients to provide comprehensive relief: **sulfacetamide sodium**, a sulfonamide antibacterial that inhibits bacterial dihydropteroate synthase (DHPS) to prevent folic acid synthesis; **naphazoline hydrochloride**, a sympathomimetic vasoconstrictor that stimulates alpha-adrenergic receptors to reduce conjunctival congestion, redness, and itching; **lidocaine hydrochloride**, a local anesthetic that blocks voltage-gated sodium channels to alleviate pain and discomfort; and **zinc phenolsulfonate** (zinc sulfophenate), which acts as a mild antiseptic and astringent. Together, these components address the infectious, inflammatory, congestive, and painful aspects of simple conjunctivitis.

Brand names
Antisettico Astringente Sedativo
Other names
Antisettico Astringente Sedativo BruschettiniAntisettico Astringente Sedativo Colliriolidocaine + naphazoline + sulfacetamide + zinc phenolsulfonatelidocaine hydrochloride + naphazoline hydrochloride + sulfacetamide sodium + zinc phenolsulfonatezinc phenolsulfonate + sulfacetamide sodium + naphazoline hydrochloride + lidocaine hydrochloridezinc sulfophenate + sulfacetamide sodium + naphazoline hydrochloride + lidocaine hydrochloride
02

Targets

ADRA1A (α1A)ADRA2A (α2A)DHPS (Dihydropteroate synthase)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Antisettico Astringente Sedativo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antisettico Astringente Sedativo.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call